Stift Carlanderska Sjukhuset
- Address
- lock Available on a paid plan
Cardiovascular Diseases Research
At Stift Carlanderska Sjukhuset, clinical trials in cardiovascular diseases focus on people at elevated risk of major heart and blood vessel events, including those with established risk factors but no prior heart attack or stroke. The studies are designed to test new approaches that may help prevent serious outcomes and improve long-term heart health.
- Preventing major adverse cardiovascular events in high-risk adults
- Reducing the risk of heart attack, stroke, and related complications
- Evaluating treatments for primary prevention of atherosclerotic cardiovascular disease
These trials mainly explore whether newer therapies can lower the chance of future coronary heart disease events and support better prevention strategies in patients with significant cardiovascular risk.
Nutritional and Metabolic Diseases Research
The site also conducts studies in nutritional and metabolic diseases, especially type 2 diabetes, obesity, and related conditions such as heart failure with preserved or mildly reduced ejection fraction. This research looks at how treatments may improve weight, blood sugar control, and broader cardiometabolic health.
- Improving outcomes in type 2 diabetes and early diabetes care
- Testing therapies for obesity and overweight with diabetes
- Studying treatments for heart failure linked to obesity and metabolic disease
Overall, the research is aimed at finding more effective ways to manage metabolic disorders while also lowering the risk of heart-related complications in people with diabetes mellitus type II and related conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Stift Carlanderska Sjukhuset
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized Controlled Trial Comparing Dapagliflozin Propanediol and Metformin in Early Stage Type 2 Diabetes for Mortality and Vascular Complications | Uppsala University | Phase III | Recruiting | Aug 2024 | — |
IMP list
lock Showing 1 of 18 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| BI 456906 | 2 | Unknown | 2024-01-18 | 2024-01-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.